Arete Wealth Advisors’s GMO US Quality ETF QLTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-40,475
Closed -$1.46M 359
2026
Q1
$1.46M Buy
40,475
+1,785
+5% +$68.5K 0.11% 184
2025
Q4
$1.49M Sell
38,690
-6,666
-15% -$251K 0.1% 196
2025
Q3
$1.64M Sell
45,356
-1,200
-3% -$41.9K 0.1% 199
2025
Q2
$1.59M Sell
46,556
-4,000
-8% -$127K 0.11% 185
2025
Q1
$1.58M Sell
50,556
-605
-1% -$19.7K 0.12% 174
2024
Q4
$1.64M Hold
51,161
0.12% 179
2024
Q3
$1.66M Sell
51,161
-3,503
-6% -$110K 0.14% 150
2024
Q2
$1.7M Sell
54,664
-9,786
-15% -$292K 0.14% 147
2024
Q1
$1.91M Buy
+64,450
New +$1.83M 0.18% 136

Other funds holding QLTY

Arete Wealth Advisors's QLTY Position: Q2 2026 in Review

Arete Wealth Advisors sold out of GMO US Quality ETF (QLTY) in Q2 2026, closing a stake of 40,475 shares — an estimated $1.46M sold.

Arete Wealth Advisors first reported a position in QLTY in Q1 2024 and held it in 9 quarters. The position peaked at $1.91M in Q1 2024. 160 funds tracked by Wall St. Rank hold QLTY as of Q2 2026.

  • Arete Wealth Advisors reported no remaining GMO US Quality ETF position as of Q2 2026 after selling out during the quarter.
  • Arete Wealth Advisors sold 40,475 GMO US Quality ETF shares in Q2 2026, an estimated $1.46M.
  • Arete Wealth Advisors first reported a position in GMO US Quality ETF in Q1 2024 and held it in 9 quarters.
  • Arete Wealth Advisors's GMO US Quality ETF position peaked at $1.91M in Q1 2024.
  • 160 funds tracked by Wall St. Rank held GMO US Quality ETF as of Q2 2026.

Based on Arete Wealth Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.